Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced it will no longer pursue the development of the NEVO? Sirolimus-Eluting Coronary Stent in order to focus on other cardiovascular therapies where significant patient need exists. The company will also stop the manufacture of CYPHER� and CYPHER SELECT� Plus Sirolimus-Eluting Coronary Stents by the end of 2011...
Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/wmYkn2fnDTM/228638.php
weight lifting lose weight
No comments:
Post a Comment